Skip to main content

Advertisement

Log in

Palliative Resection of Colorectal Cancer: Does It Prolong Survival?

  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

It is still a matter of debate as to whether resective surgery of the primary tumor may prolong the survival of patients affected by incurable colorectal cancer (CRC). The main goal of this retrospective study, carried out on patients not undergoing any therapy other than surgery, was to quantify the benefit of primary tumor removal in patients with differently presenting incurable CRC.

Methods

One hundred and thirty consecutive patients were operated on for incurable CRC (83 undergoing resective and 47 non-resective procedures). With the purpose of comparing homogenous populations and of identifying patients who may benefit from primary tumor resection, the patients were classified according to classes of disease, based on the “metastatic pattern” and the “resectability of primary tumor.”

Results

In patients with “resectable” primary tumors, resective procedures are associated with longer median survival than after non-resective ones (9 months vs 3). Only patients with distant spread without neoplastic ascites/carcinosis benefit from primary tumor removal (median survival: 9 months vs 3). Morbidity and mortality of resective procedures is not significantly different from that of non-resective surgery, either in the population studied or in any of the groups considered.

Conclusions

Palliative resection of primary CRC should be pursued in patients with unresectable distant metastasis (without carcinomatosis), and, intraoperatively, whenever the primary tumor is technically resectable.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

FIG. 1.
FIG. 2.
FIG. 3.

Similar content being viewed by others

References

  1. Mella J, Biffin A, Radcliffe AG, Stamatakis JD, Steele RJ. Population-based audit of colorectal cancer management in two UK health regions. Colorectal Cancer Working Group, Royal College of Surgeons of England Clinical Epidemiology and Audit Unit. Br J Surg 1997; 84:1731–6

    Article  PubMed  CAS  Google Scholar 

  2. Makela J, Haukipuro K, Laitinen S, Kairaluoma MI. Palliative operations for colorectal cancer. Dis Colon Rectum 1990; 33:846–50

    Article  PubMed  CAS  Google Scholar 

  3. Liu SK, Church JM, Lavery IC, Fazio VW. Operation in patients with incurable colon cancer—–is it worthwhile? Dis Colon Rectum 1997; 40:11–4

    Article  PubMed  CAS  Google Scholar 

  4. Ruo L, Gougoutas C, Paty PB, Guillem JG, Cohen AM, Wong WD. Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. Am Coll Surg 2003; 196:722–8

    Article  Google Scholar 

  5. Scoggins CR, Meszoely IM, Blanke CD, Beauchamp RD, Leach SD. Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol 1999; 6:651–7

    Article  PubMed  CAS  Google Scholar 

  6. Sarela AI, Guthrie JA, Seymour MT, Ride E, Guillou PJ, O’Riordain DS. Non-operative management of the primary tumour in patients with incurable stage IV colorectal cancer. Br J Surg 2001; 8:1352–6

    Article  Google Scholar 

  7. Carne PW, Frye JN, Robertson GM, Frizelle FA. Stents or open operation for palliation of colorectal cancer: a retrospective, cohort study of perioperative outcome and long-term survival. Dis Colon Rectum 2004; 47:1455–61

    Article  PubMed  Google Scholar 

  8. Benoist S, Pautrat K, Mitry E, Rougier P, Penna C, Nordlinger B. Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Surg 2005; 92:1155–60

    Article  PubMed  CAS  Google Scholar 

  9. Milsom JW, Kim SH, Hammerhofer KA, Fazio VW. Laparoscopic colorectal cancer surgery for palliation. Dis Colon Rectum 2000; 43:1512–6

    Article  PubMed  CAS  Google Scholar 

  10. Michel P, Roque I, Di Fiore F, Langlois S, Scotte M, Teniere P, Paillot B. Colorectal cancer with non-resectable synchronous metastases: should the primary tumor be resected? Gastroenterol Clin Biol 2004; 28:434–7

    Article  PubMed  Google Scholar 

  11. Rosen SA, Buell JF, Yoshida A, et al. Initial presentation with stage IV colorectal cancer: how aggressive should we be? Arch Surg 2000; 135:530–4

    Article  PubMed  CAS  Google Scholar 

  12. Nash GM, Saltz LB, Kemeny NE, et al. Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease. Ann Surg Oncol 2002; 9:954–60

    Article  PubMed  Google Scholar 

  13. Kuo LJ, Leu SY, Liu MC, Jian JJ, Hongiun Cheng S, Chen CM. How aggressive should we be in patients with stage IV colorectal cancer? Dis Colon Rectum 2003; 46:1646–52

    Article  PubMed  Google Scholar 

  14. Cummins ER, Vick KD, Poole GV. Incurable colorectal carcinoma: the role of surgical palliation. Am Surg 2004; 70:433–7

    PubMed  Google Scholar 

  15. Martin R, Paty P, Fong Y, et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 2003; 197:233–41

    Article  PubMed  Google Scholar 

  16. Cook AD, Single R, McCahill LE. Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of surveillance, epidemiology, and end results data, 1988 to 2000. Ann Surg Oncol 2005; 12:637–45

    Article  PubMed  Google Scholar 

  17. Law WL, Chan WF, Lee YM, Chu KW. Non-curative surgery for colorectal cancer: critical appraisal of outcomes. Int J Colorectal Dis 2004; 19:197–202

    Article  PubMed  Google Scholar 

  18. Becouarn Y, Gamelin E, Coudert B, et al. Randomized multicenter phase II study comparing a combination of fluorouracil and folinic acid and alternating irinotecan and oxaliplatin with oxaliplatin and irinotecan in fluorouracil-pretreated metastatic colorectal cancer patients. J Clin Oncol 2001; 19:4195–201

    PubMed  CAS  Google Scholar 

  19. Vamvakas L, Kakolyris S, Kouroussis C, et al. Irinotecan (CPT-11) in combination with infusional 5-fluorouracil and leucovorin (de Gramont regimen) as first-line treatment in patients with advanced colorectal cancer: a multicenter phase II study. Am J Clin Oncol 2002; 25:65–70

    Article  PubMed  CAS  Google Scholar 

  20. Courtney ED, Raja A, Leicester RJ. Eight years experience of high-powered endoscopic diode laser therapy for palliation of colorectal carcinoma. Dis Colon Rectum 2005; 48:845–50

    Article  PubMed  Google Scholar 

  21. Chen H, George BD, Kaufman HS, Malaki MB, Mortensen NJ, Kettlewell MG. Endoscopic transanal resection provides palliation equivalent to transabdominal resection in patients with metastatic rectal cancer. J Gastrointest Surg 2001; 5:282–6

    Article  PubMed  CAS  Google Scholar 

  22. Law WL, Choi HK, Chu KW. Comparison of stenting with emergency surgery as palliative treatment for obstructing primary left-sided colorectal cancer. Br J Surg 2003; 90: 429–33

    Article  Google Scholar 

  23. Milsom JW, Jerby BL, Kessler H, Hale JC, Herts BR, O’Malley CM. Prospective, blinded comparison of laparoscopic ultrasonography vs. contrast-enhanced computerized tomography for liver assessment in patients undergoing colorectal carcinoma surgery. Dis Colon Rectum 2000; 43:44–9

    Article  PubMed  CAS  Google Scholar 

  24. Modlin J, Hellis H. Palliative resections in cancer of the colon and rectum. Cancer 1949; 2:767–76

    Article  CAS  PubMed  Google Scholar 

  25. Stearns MW Jr, Bikley GE. Palliative surgery for surgery of the rectum and colon. Cancer 1954; 7:1016–9

    Article  PubMed  Google Scholar 

  26. Longo WE, Ballantyne GH, Bilchik AJ, Modlin IM. Advanced rectal cancer. What is the best palliation? Dis Colon Rectum 1988; 31:842–7

    Article  PubMed  CAS  Google Scholar 

  27. Bacon HE, Martin PV. The rationale of palliative resection for primary cancer of the colon and rectum complicated by liver and lung metastasis. Dis Colon Rectum 1964; 36:211–7

    Article  Google Scholar 

  28. Joffe J, Gordon PH. Palliative resection for colorectal carcinoma. Dis Colon Rectum 1981; 24:355–60

    Article  PubMed  CAS  Google Scholar 

  29. Harris GJC, Senagore AJ, Lavery IC, Church JM, Fazio VW. Factors affecting survival after palliative resection of colorectal carcinoma. Colorectal Dis 2002; 4:31–5

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

The authors wish to acknowledge Nathalie Bataille, MD, Thierry Montariol, MD, (Service de Chirurgie Viscérale, Hôpital de St.-Germain-en-Laye, France) and Michaël Azagury, MD (Service de Cancerologie, Hôpital de St.-Germain-en-Laye, France) for their contribution in the reviewing process of the article. The authors acknowledge The University of Parma for financial support (Research Funds).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Renato Costi MD, PhD.

Additional information

This paper has not been presented to any society or meeting.

Authors’ Contribution: RC: Ideation, drawing, and drafting of the article; AM: Collection of data, drafting of the article; DD: Collection of data, drafting of the article; LV: Statistical analysis, epidemiological data; GS: Statistical analysis; VV: Important intellectual contribution, field expertise; LR: Supervision, important intellectual contribution; LS: Supervision, important intellectual contribution, final review

Rights and permissions

Reprints and permissions

About this article

Cite this article

Costi, R., Mazzeo, A., Di Mauro, D. et al. Palliative Resection of Colorectal Cancer: Does It Prolong Survival?. Ann Surg Oncol 14, 2567–2576 (2007). https://doi.org/10.1245/s10434-007-9444-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-007-9444-2

Keywords

Navigation